Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

62462 1500648800HCLSReviewMexicoJuly2017.pdf
Energy Boardroom

Bayer signs €50m deal for Orion's prostate cancer drug

03.06.2014 / Scripintelligence

Bayer and Orion will jointly develop the drug, with Bayer contributing a major share of the costs of future development and retaining global commercialization rights. Orion will have the option to co-promote the drug in Europe and will be responsible for…

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: